HUMAN T-CELL LUEKEMIA VIRUS (HTLV)
|
Structure
& Property |
Transmission |
Pathogenesis |
Clinical
findings |
Laboratory
diagnosis |
Treatment |
|
Family: retrovirus Genome: single strand RNA, 2 segments, +ve polarity. Size: 100nm Icosahedral nucleocapsid Spherical enveloped particles surrounded by spikes or knobs. Two types: - HTLV-1 - HTLV-II: similar structurally with extensive nucleic acid homology with HTLV-1. |
Sexual, vertical (via breast milk) and by blood – transfused blood is hihgly infectious. Occurs in Japan, the Caribbean & West Africa. |
The CD4 receptors on the T cells are the receptors for these viruses. HTLV-I and II transform and cause the T cells to proliferate. Role of tax protein: - acts on viral LTR sequences to stimulate viral mRNA synthesis. - increase production of IL-2 and IL-2 receptor. |
Incubation period: symptoms appear after a prolonged period –usually many years. T cell leukemia: - an aggressive malignancy of T cells, with lymphadenopathy and hepatosplenomegaly; sometimes with cerebral involvement. - may present with lymphomatous infiltration of the skin. - increased level of calcium in blood due to osteoporotic lesions. Tropical spastic paraparesis: a progressive non-demyelinating spastic paralysis, more common in females than males. Symptomless infections: most people do not develop disease. Antibody persists throughout infection. |
Grows in culture in human T cells stimulated with IL-2; cells are transformed or immortalized without CPE. Detected by EM. HTLV-I and II can be distinguished serologically and by differences in their gene sequences using products of PCR. |
No antiviral or vaccine available. AZT: first line therapy. |